7 Keto Abiraterone Acetate
● In Stock
| Catalogue No.: | VL830001 |
|---|---|
| CAS No.: | N/A |
| Mol. Formula: | C26H31NO3 |
| Mol. Weight: | 405.53 g/mol |
Additional information on 7 Keto Abiraterone Acetate
Parent drug
AbirateroneIUPAC Name
(3S, 8R, 9S, 10R, 13S, 14S)-10, 13-Dimethyl-7-oxo-17-(pyridin-3-yl)-2, 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl AcetatePharmacopoeial Synonyms
N/AOther Synonyms
N/ASmiles
CC(O[C@H](CC1=C2)CC[C@]1(C)[C@@]3([H])CC[C@]4(C)C(C5=CC=CN=C5)=CC[C@@]4([H])[C@]3([H])C2=O)=OInchl
InChI=1S/C26H31NO3/c1-16(28)30-19-8-10-25(2)18(13-19)14-23(29)24-21-7-6-20(17-5-4-12-27-15-17)26(21,3)11-9-22(24)25/h4-6,12,14-15,19,21-22,24H,7-11,13H2,1-3H3/t19-,21-,22-,24-,25-,26+/m0/s1Description
The compound 7 Keto Abiraterone Acetate is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines, including those from USP, EMA, JP, and BP. It is ideal for critical applications such as analytical method development, method validation (AMV), and quality control (QC), especially in the production of Abiraterone. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), this product delivers the precision required for reliable results. Additionally, it includes a detailed Structure Elucidation Report (SER), ensuring accuracy and dependability for advanced analytical purposes. 7 Keto Abiraterone Acetate or (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-7-oxo-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl Acetate, is an antiandrogen class and it is a used in the treatment a certain type of prostate cancer.
References
Thakur, Abhimanyu, et al. “Abiraterone Acetate in the Treatment of Prostate Cancer.†Biomedicine & Pharmacotherapy, vol. 101, May 2018, pp. 211–218, 10.1016/j.biopha.2018.02.067.Request a Quote
« * » indique les champs nécessaires









